These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 35789548)
21. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma. Cheng J; Chen F; Cheng Y Cells; 2022 Oct; 11(21):. PubMed ID: 36359828 [TBL] [Abstract][Full Text] [Related]
22. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
24. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients. Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958 [TBL] [Abstract][Full Text] [Related]
25. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
26. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma. Wang P; Chen Y; Zheng Y; Fu Y; Ding Z Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369 [TBL] [Abstract][Full Text] [Related]
27. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma. Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352 [TBL] [Abstract][Full Text] [Related]
28. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration. Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848 [TBL] [Abstract][Full Text] [Related]
29. Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma. Pan M; Wang Y; Wang Z; Shao C; Feng Y; Ding P; Duan H; Ren X; Duan W; Ma Z; Yan X Aging (Albany NY); 2023 Apr; 15(8):3094-3106. PubMed ID: 37071001 [TBL] [Abstract][Full Text] [Related]
30. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713 [TBL] [Abstract][Full Text] [Related]
31. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures. Guo J; Tong C; Shi J; Li X; Chen X Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829 [TBL] [Abstract][Full Text] [Related]
32. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data. Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975 [TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus. Xue J; Jia E; Ren N; Xin H Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850 [TBL] [Abstract][Full Text] [Related]
34. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma. Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253 [TBL] [Abstract][Full Text] [Related]
35. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma. Zhang J; Ling X; Fang C; Ma J Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166 [TBL] [Abstract][Full Text] [Related]
36. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma. Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y Front Immunol; 2023; 14():1117658. PubMed ID: 36817484 [TBL] [Abstract][Full Text] [Related]
37. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S Front Immunol; 2022; 13():918154. PubMed ID: 35880180 [TBL] [Abstract][Full Text] [Related]
38. [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes]. Liu HR; Jiang GZ; Xin D; Yang YL; Fan QX; Meng XR; Li SL; Liu Y; Xia J; Wang F Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):666-673. PubMed ID: 34289558 [No Abstract] [Full Text] [Related]
39. Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma. Zhang X; Feng N; Wu B; Guo Z; Pan T; Tao X; Zheng H; Zhang W Aging (Albany NY); 2023 Oct; 15(19):10473-10500. PubMed ID: 37812189 [TBL] [Abstract][Full Text] [Related]
40. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma. Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]